These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37499882)

  • 1. Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
    Avantaggiato F; Farokhniaee A; Bandini A; Palmisano C; Hanafi I; Pezzoli G; Mazzoni A; Isaias IU
    Neurobiol Dis; 2023 Sep; 185():106239. PubMed ID: 37499882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
    Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Low versus High Frequency Subthalamic Deep Brain Stimulation on Speech Intelligibility and Verbal Fluency in Parkinson's Disease: A Double-Blind Study.
    Grover T; Georgiev D; Kalliola R; Mahlknecht P; Zacharia A; Candelario J; Hyam J; Zrinzo L; Hariz M; Foltynie T; Limousin P; Jahanshahi M; Tripoliti E
    J Parkinsons Dis; 2019; 9(1):141-151. PubMed ID: 30594934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
    Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
    Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Brain Stimulation of the Subthalamic Nucleus Parameter Optimization for Vowel Acoustics and Speech Intelligibility in Parkinson's Disease.
    Knowles T; Adams S; Abeyesekera A; Mancinelli C; Gilmore G; Jog M
    J Speech Lang Hear Res; 2018 Mar; 61(3):510-524. PubMed ID: 29471373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease.
    Pinto S; Nebel A; Rau J; Espesser R; Maillochon P; Niebuhr O; Krack P; Witjas T; Ghio A; Cuartero MC; Timmermann L; Schnitzler A; Hesekamp H; Meier N; Müllner J; Hälbig TD; Möller B; Paschen S; Paschen L; Volkmann J; Barbe MT; Fink GR; Becker J; Reker P; Kühn AA; Schneider GH; Fraix V; Seigneuret E; Kistner A; Rascol O; Brefel-Courbon C; Ory-Magne F; Hartmann CJ; Wojtecki L; Fradet A; Maltête D; Damier P; Le Dily S; Sixel-Döring F; Benecke P; Weiss D; Wächter T; Pinsker MO; Régis J; Thobois S; Polo G; Houeto JL; Hartmann A; Knudsen K; Vidailhet M; Schüpbach M; Deuschl G;
    Mov Disord; 2023 Feb; 38(2):212-222. PubMed ID: 36461899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Contralateral Deep Brain Stimulation and Levodopa on Subthalamic Nucleus Oscillatory Activity and Phase-Amplitude Coupling.
    Farokhniaee A; Marceglia S; Priori A; Lowery MM
    Neuromodulation; 2023 Feb; 26(2):310-319. PubMed ID: 36513587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
    Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic deep brain stimulation aggravates speech problems in Parkinson's disease: Objective and subjective analysis of the influence of stimulation frequency and electrode contact location.
    Phokaewvarangkul O; Boonpang K; Bhidayasiri R
    Parkinsonism Relat Disord; 2019 Sep; 66():110-116. PubMed ID: 31327627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease.
    Tripoliti E; Zrinzo L; Martinez-Torres I; Frost E; Pinto S; Foltynie T; Holl E; Petersen E; Roughton M; Hariz MI; Limousin P
    Neurology; 2011 Jan; 76(1):80-6. PubMed ID: 21068426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programming Algorithm for the Management of Speech Impairment in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
    Swinnen BEKS; Lotfalla V; Scholten MN; Prins RHN; Goes KM; de Vries S; Geytenbeek JJM; Dijk JM; Odekerken VJ; Bot M; van den Munckhof P; Schuurman PR; de Bie RMA; Beudel M
    Neuromodulation; 2024 Apr; 27(3):528-537. PubMed ID: 37452799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Unilateral Subthalamic Nucleus Deep Brain Stimulation on Contralateral Subthalamic Nucleus Local Field Potentials.
    Hasegawa H; Fischer P; Tan H; Pogosyan A; Samuel M; Brown P; Ashkan K
    Neuromodulation; 2020 Jun; 23(4):509-514. PubMed ID: 32281215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease.
    Gessani A; Cavallieri F; Fioravanti V; Campanini I; Merlo A; Di Rauso G; Damiano B; Scaltriti S; Bardi E; Corni MG; Antonelli F; Cavalleri F; Molinari MA; Contardi S; Menozzi E; Fraternali A; Versari A; Biagini G; Fraix V; Pinto S; Moro E; Budriesi C; Valzania F
    Sci Rep; 2023 Jul; 13(1):11462. PubMed ID: 37454168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic nucleus stimulation effects on single and combined task performance in Parkinson's disease patients: a PET study.
    Atkinson-Clement C; Maillet A; LeBars D; Lavenne F; Redouté J; Krainik A; Pollak P; Thobois S; Pinto S
    Brain Imaging Behav; 2017 Aug; 11(4):1139-1153. PubMed ID: 27704407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysarthria and Speech Intelligibility Following Parkinson's Disease Globus Pallidus Internus Deep Brain Stimulation.
    Chiu SY; Tsuboi T; Hegland KW; Herndon NE; Shukla AW; Patterson A; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    J Parkinsons Dis; 2020; 10(4):1493-1502. PubMed ID: 32955467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson's disease.
    Tripoliti E; Limousin P; Foltynie T; Candelario J; Aviles-Olmos I; Hariz MI; Zrinzo L
    Mov Disord; 2014 Apr; 29(4):532-8. PubMed ID: 24532491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local field potential activity dynamics in response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Wiest C; Tinkhauser G; Pogosyan A; Bange M; Muthuraman M; Groppa S; Baig F; Mostofi A; Pereira EA; Tan H; Brown P; Torrecillos F
    Neurobiol Dis; 2020 Sep; 143():105019. PubMed ID: 32681881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct subthalamic nucleus stimulation influences speech and voice quality in Parkinson's disease patients.
    Bobin M; Sulzer N; Bründler G; Staib M; Imbach LL; Stieglitz LH; Krauss P; Bichsel O; Baumann CR; Frühholz S
    Brain Stimul; 2024; 17(1):112-124. PubMed ID: 38272256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.